86.90.E - Healthcare
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.10.Z - Hospital activities
86.22.Z - Specialist medical practice
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1485,6 | |||
Gross profit (loss) | -0 | 0,5 | 0,2 | -49,2 |
EBITDA | -0 | 0,5 | 0,3 | -33,1 |
Short time liabilities | 0 | 0 | 0,2 | 762 |
Other operating costs | 42 175 | |||
Equity capital | 0 | 0,5 | 0,7 | 44,3 |
Operating profit (EBIT) | -0 | 0,5 | 0,2 | -48,5 |
Assets | 0,1 | 0,5 | 0,9 | 75,3 |
Net profit (loss) | -0 | 0,4 | 0,2 | -50,6 |
Cash | 0 | 0,2 | 0,1 | -67,2 |
Net income from sale | 0,3 | 1,4 | 1,1 | -18,9 |
Liabilities and provisions for liabilities | 0 | 0 | 0,2 | 762 |
Working assets | 0,1 | 0,3 | 0,3 | 0,9 |
Other income costs | 456 562,5 | |||
Depreciation | 0 | 0 | 0,1 | 156,4 |
% | % | % | p.p. | |
Profitability of capital | -8,4 | 89,6 | 30,7 | -58,9 |
Equity capital to total assets | 63,5 | 95,7 | 78,8 | -16,9 |
Gross profit margin | -1,3 | 34,1 | 21,3 | -12,8 |
EBITDA Margin | -1,5 | 36,9 | 30,4 | -6,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 19 | 6 | 62 | 56 |
Current financial liquidity indicator | 4.596415996551514 | 13.663415908813477 | 1.599147915840149 | -12,1 |
Net dept to EBITDA | 8.358638763427734 | -0.48597490787506104 | 0.15380892157554626 | 0,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane